Search

William P. Neuder

Examiner (ID: 10341)

Most Active Art Unit
3672
Art Unit(s)
3672, 2899, 3625, 3642, 3506
Total Applications
4583
Issued Applications
4090
Pending Applications
166
Abandoned Applications
332

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20192259 [patent_doc_number] => 20250268969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-08-28 [patent_title] => OPHTHALMIC COMPOSITION [patent_app_type] => utility [patent_app_number] => 18/251611 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6767 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18251611 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/251611
OPHTHALMIC COMPOSITION Oct 4, 2021 Pending
Array ( [id] => 17426828 [patent_doc_number] => 20220054536 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-24 [patent_title] => NITRIC OXIDE TOPICAL APPLICATION APPARATUS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/494180 [patent_app_country] => US [patent_app_date] => 2021-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6933 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17494180 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/494180
NITRIC OXIDE TOPICAL APPLICATION APPARATUS AND METHODS Oct 4, 2021 Abandoned
Array ( [id] => 18784790 [patent_doc_number] => 20230372424 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-11-23 [patent_title] => ANTIVIRAL ACTIVE CINNAMON EXTRACT AND PROCESS [patent_app_type] => utility [patent_app_number] => 18/246911 [patent_app_country] => US [patent_app_date] => 2021-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5827 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246911 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/246911
ANTIVIRAL ACTIVE CINNAMON EXTRACT AND PROCESS Sep 30, 2021 Pending
Array ( [id] => 17341376 [patent_doc_number] => 20220007707 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => CANNABIS CALIBRATION SYSTEM-DERIVED PRODUCTS AND METHOD OF MAKING SAME [patent_app_type] => utility [patent_app_number] => 17/485447 [patent_app_country] => US [patent_app_date] => 2021-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9569 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 126 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17485447 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/485447
CANNABIS CALIBRATION SYSTEM-DERIVED PRODUCTS AND METHOD OF MAKING SAME Sep 25, 2021 Pending
Array ( [id] => 17342162 [patent_doc_number] => 20220008493 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => METHOD FOR INCREASING THC/CBD CONTENT IN A CANNABIS PRODUCT [patent_app_type] => utility [patent_app_number] => 17/485446 [patent_app_country] => US [patent_app_date] => 2021-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10435 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17485446 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/485446
METHOD FOR INCREASING THC/CBD CONTENT IN A CANNABIS PRODUCT Sep 25, 2021 Pending
Array ( [id] => 18970359 [patent_doc_number] => 20240050451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-02-15 [patent_title] => PRECISION CANNABINOID THERAPY FORMULATIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/246613 [patent_app_country] => US [patent_app_date] => 2021-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49961 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18246613 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/246613
PRECISION CANNABINOID THERAPY FORMULATIONS AND METHODS OF USE Sep 23, 2021 Pending
Array ( [id] => 19232119 [patent_doc_number] => 20240189310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-13 [patent_title] => PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291 [patent_app_type] => utility [patent_app_number] => 17/478117 [patent_app_country] => US [patent_app_date] => 2021-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12707 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 121 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17478117 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/478117
PHARMACEUTICAL COMPOSITIONS COMPRISING AZD9291 Sep 16, 2021 Abandoned
Array ( [id] => 19608083 [patent_doc_number] => 12156942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-12-03 [patent_title] => Sustained delivery of therapeutic agents to an eye compartment [patent_app_type] => utility [patent_app_number] => 17/475528 [patent_app_country] => US [patent_app_date] => 2021-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15945 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 158 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17475528 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/475528
Sustained delivery of therapeutic agents to an eye compartment Sep 14, 2021 Issued
Array ( [id] => 17297730 [patent_doc_number] => 20210393569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-23 [patent_title] => Taxane Particles and Their Use [patent_app_type] => utility [patent_app_number] => 17/467655 [patent_app_country] => US [patent_app_date] => 2021-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13220 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17467655 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/467655
Taxane Particles and Their Use Sep 6, 2021 Abandoned
Array ( [id] => 17290852 [patent_doc_number] => 20210386691 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-16 [patent_title] => Oral Dosage Forms of Ketamine [patent_app_type] => utility [patent_app_number] => 17/460476 [patent_app_country] => US [patent_app_date] => 2021-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9154 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17460476 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/460476
Method for treatment of depression with oral dosage forms of ketamine Aug 29, 2021 Issued
Array ( [id] => 18707595 [patent_doc_number] => 20230330172 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-19 [patent_title] => COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION [patent_app_type] => utility [patent_app_number] => 18/023119 [patent_app_country] => US [patent_app_date] => 2021-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9356 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18023119 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/023119
COMPOSITION FOR AMELIORATING UNPLEASANT STATE CAUSED BY MENSTRUATION Aug 24, 2021 Pending
Array ( [id] => 18690953 [patent_doc_number] => 20230321125 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => COMPOSITIONS OF GINSENOSIDE RG3 AND GINSENOSIDE RG5 AND THEIR PHARMACEUTICAL USES INCLUDING ANTI-TUMOR EFFECTS [patent_app_type] => utility [patent_app_number] => 18/022372 [patent_app_country] => US [patent_app_date] => 2021-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12783 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 423 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18022372 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/022372
COMPOSITIONS OF GINSENOSIDE RG3 AND GINSENOSIDE RG5 AND THEIR PHARMACEUTICAL USES INCLUDING ANTI-TUMOR EFFECTS Aug 19, 2021 Abandoned
Array ( [id] => 17242062 [patent_doc_number] => 20210361805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-11-25 [patent_title] => ANTI-ODOR COMPOSITIONS, STRUCTURES HAVING ANTI-ODOR CHARACTERISTICS, METHODS OF MAKING THE ANTI-ODOR COMPOSITIONS AND THE STRUCTURES [patent_app_type] => utility [patent_app_number] => 17/398413 [patent_app_country] => US [patent_app_date] => 2021-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7174 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17398413 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/398413
Anti-odor compositions, structures having anti-odor characteristics, methods of making the anti-odor compositions and the structures Aug 9, 2021 Issued
Array ( [id] => 18596014 [patent_doc_number] => 20230270805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-31 [patent_title] => A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF [patent_app_type] => utility [patent_app_number] => 18/018473 [patent_app_country] => US [patent_app_date] => 2021-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14051 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18018473 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/018473
A COMPOSITION COMPRISING AN EXTRACT OF ALDER TREE OR THE ISOLATED COMPOUNDS THEREFROM FOR TREATING AND PREVENTING SKELETON MUSCLE-RELATED DISORDER AND THE USE THEREOF Aug 2, 2021 Pending
Array ( [id] => 19279982 [patent_doc_number] => 20240216455 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-04 [patent_title] => NON-STEROIDAL TOPICAL COMPOSITION AND METHOD THEREOF [patent_app_type] => utility [patent_app_number] => 17/916806 [patent_app_country] => US [patent_app_date] => 2021-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3598 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -6 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17916806 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/916806
NON-STEROIDAL TOPICAL COMPOSITION AND METHOD THEREOF Jul 22, 2021 Pending
Array ( [id] => 18626625 [patent_doc_number] => 20230285422 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH MUTATIONS IN THE SYNGAPI GENE [patent_app_type] => utility [patent_app_number] => 18/005848 [patent_app_country] => US [patent_app_date] => 2021-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3982 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18005848 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/005848
USE OF CANNABIDIOL IN THE TREATMENT OF SEIZURES ASSOCIATED WITH MUTATIONS IN THE SYNGAPI GENE Jul 14, 2021 Pending
Array ( [id] => 18647839 [patent_doc_number] => 20230293614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-21 [patent_title] => COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES [patent_app_type] => utility [patent_app_number] => 18/016189 [patent_app_country] => US [patent_app_date] => 2021-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24264 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -37 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18016189 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/016189
COMPOSITIONS AND METHODS OF TREATING UPS-ASSOCIATED DISEASES Jul 12, 2021 Pending
Array ( [id] => 18691056 [patent_doc_number] => 20230321249 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-10-12 [patent_title] => DRUG-CLAY MINERAL COMPLEX CONTAINING PHOSPHOLIPID AND ORAL ADMINISTRATION COMPOSITION INCLUDING SAME [patent_app_type] => utility [patent_app_number] => 18/013919 [patent_app_country] => US [patent_app_date] => 2021-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9278 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013919 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/013919
DRUG-CLAY MINERAL COMPLEX CONTAINING PHOSPHOLIPID AND ORAL ADMINISTRATION COMPOSITION INCLUDING SAME Jun 30, 2021 Pending
Array ( [id] => 17512583 [patent_doc_number] => 11291701 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2022-04-05 [patent_title] => Orally disintegrating, sublingual and buccal formulations [patent_app_type] => utility [patent_app_number] => 17/353149 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3706 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17353149 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/353149
Orally disintegrating, sublingual and buccal formulations Jun 20, 2021 Issued
Array ( [id] => 18656199 [patent_doc_number] => 20230302079 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-28 [patent_title] => SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS [patent_app_type] => utility [patent_app_number] => 18/011335 [patent_app_country] => US [patent_app_date] => 2021-06-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9011 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011335 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/011335
SAPONIN CONTAINING EXTRACTS PREPARED FROM HESPERALOE USEFUL IN THE TREATMENT OF NON-HUMAN ANIMALS Jun 20, 2021 Pending
Menu